CHINESE JOURNAL OF MEDICINAL GUIDE >
Research and Practice on the Construction of National Integrated Drug Administration Data Resource System
Received date: 2025-07-04
Revised date: 2025-08-28
Accepted date: 2025-12-03
Online published: 2025-12-17
The year 2025 marks a crucial period for the full completion of the 14th Five-Year Plan and the strategic planning of the 15th Five-Year Plan. This study reviews the development and achievements of China's drug administration data resource system from the periods of the 12th Five-Year Plan and earlier up to the 14th Five-Year Plan. It also summarizes the measures and achievements of the Center for Information of the National Medical Products Administration (NMPA) in establishing a national drug administration data resource support system, creating a unified channel for the aggregation and sharing of national drug administration data resources, and deepening the application services of drug administration data resources. This study identifies issues in drug administration data resources, including the inadequacy of current data quality to fully meet the demands of innovative applications, insufficient integration and application with social data, and limited fusion with innovative technologies such as artificial intelligence, and puts forward recommendations for future work, with a view to provide references for the planning and construction of the drug administration data resource system during the 15th Five-Year Plan and beyond. It is suggested to improve the data governance systems, explore new data governance technologies, and continuously enhance data quality; expedite the introduction of administration frameworks and implementation guidelines for the authorized operation of drug administration data resources, and research the establishment of a trusted data space in the field of drug administration to fully unlock the value of data; actively integrate innovative technologies, explore mechanisms for the generation, sharing, and application of data resources such as knowledge bases and high-quality datasets required for artificial intelligence, and apply artificial intelligence technologies to enhance the efficiency of data governance and analysis.
Wan-chen Tang . Research and Practice on the Construction of National Integrated Drug Administration Data Resource System[J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025 , 27(10) : 1095 -1095-1100 . DOI: magtech.2025.07.04-00002
[1] 中国政府网.中共中央 国务院印发《数字中国建设整体布局规划》[EB/OL].(2023-02-07)[2025-07-20].https://www.gov.cn/xinwen/2023-02/27/content_5743484.htm.
[2] 国家数据局.国家数据局等部门关于印发《“数据要素×”三年行动计划(2024—2026年)》的通知[EB/OL].(2024-01-05)[2025-07-19].https://www.cac.gov.cn/2024-01/05/c_1706119078060945.htm.
[3] 国务院.国务院关于印发“十四五”数字经济发展规划的通知[EB/OL].(2021-12-12)[2025-07-19].https://www.gov.cn/gongbao/content/2022/content_5671108.htm.
[4] 国务院办公厅. 国务院办公厅关于印发全国一体化政务大数据体系建设指南的通知[EB/OL].(2022-09-13)[2025-07-19].https://www.gov.cn/gongbao/content/2022/content_5725276.htm.
[5] 张玥,陆颖,刘洋.食品药品监管信息化项目管理优化策略研究[J].中国医药导刊,2017,19(11):1245-1249.
[6] 马进.以建设药品品种档案为例探讨主数据管理在药品监管领域的应用[J].中国药事,2018,32(9):1172-1175.
[7] 宗欣,王迎利.浅谈大数据时代食品药品监管数据资源的综合管理[J].中国药物评价,2017,34(1):71-73.
[8] 国务院.中华人民共和国政府信息公开条例[EB/OL].(2007-04-05)[2025-07-19].https://www.gov.cn/gongbao/content/2007/content_621230.htm.
[9] 国务院.国务院关于印发国家药品安全“十二五”规划的通知[EB/OL].(2012-01-20)[2025-07-20].https://www.nmpa.gov.cn/directory/web/nmpa/zwgk/ghcw/ghjh/20120120120001213_4.html.
[10] 国家药品监督管理基础数据库重构项目通过初步验收[J].中国医药导刊,2015,17(5):454.
[11] 新华社.中华人民共和国国民经济和社会发展第十三个五年规划纲要[EB/OL].(2016-03-17)[2025-07-19].https://www.gov.cn/xinwen/2016-03/17/content_5054992.htm.
[12] 国务院.国务院关于印发政务信息资源共享管理暂行办法的通知[EB/OL].(2016-09-05)[2025-07-19].https://www.gov.cn/gongbao/content/2016/content_5115838.htm.
[13] 国务院.国务院关于印发“十三五”国家食品安全规划和“十三五”国家药品安全规划的通知[EB/OL].(2017-02-21)[2025-07-20].https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjzh/20170221221501454.html.
[14] 新华社.中华人民共和国国民经济和社会发展第十四个五年规划和2035年远景目标纲要[EB/OL].(2021-03-13)[2025-07-19].https://www.gov.cn/xinwen/2021-03/13/content_5592681.htm.
[15] 国家药品监督管理局等.“十四五”国家药品安全及促进高质量发展规划[EB/OL].(2021-12-30)[2025-07-19].https://www.nmpa.gov.cn/zwgk/ghcw/ghjh/20211230192314164.html.
[16] 中共中央,国务院. 中共中央 国务院关于构建数据基础制度更好发挥数据要素作用的意见[EB/OL].(2022-12-02)[2025-07-19].https://www.gov.cn/gongbao/content/2023/content_5736707.htm.
[17] 中共中央办公厅,国务院办公厅.中共中央办公厅 国务院办公厅关于加快公共数据资源开发利用的意见[EB/OL].(2024-09-21)[2025-07-19].https://www.gov.cn/gongbao/2024/issue_11666/202410/content_6983475.html.
[18] 国务院办公厅. 国务院办公厅关于全面加强药品监管能力建设的实施意见[EB/OL].(2021-05-10)[2025-04-03].https://www.gov.cn/zhengce/content/2021-05/10/content_5605628.htm.
[19] 唐菀晨,孙浩,由玉伟,等.基于两级数据中心的药品监管数据治理实践与思考[J].中国医药工业杂志,2024,55(7):1037-1043.
[20] 国家药品监督管理局信息中心.“全国互联一网协同 基于药品监管领域跨省协同探索与实践”入选2024数字政府卓越贡献类创新实践案例[EB/OL].(2024-08-29)[2025-04-03].https://www.cpi.ac.cn/zx/xyzl/202408/t20240829_424929.html.
[21] 张喆,李桂桂,张京梅,等.国家药监局政务服务平台场景分析及工作推进思路[J].中国医药导刊,2020,22(7):506-512.
[22] 杨彦彬.DAMA数据管理知识体系指南在实践中的思考与改进[J].图书情报导刊,2025,10(5):53-59.
[23] 陈锋,吴欣然.药品监管领域大语言模型(LLM)一体化建设策略研究[J].中国医药导刊,2025,27(1):1-6.
[24] 门理想,魏筠筵.公共数据授权运营何以跨域协同:动机、能力与机制[J/OL].电子政务,1-12[2025-07-20].http://kns.cnki.net/kcms/detail/11.5181.TP.20250328.1348.010.html.
[25] 赵一鸣,黄丹迪.我国可信数据空间的建设原则与发展路径[J].现代情报,2025,45(6):126-139.
/
| 〈 |
|
〉 |